Anesthesia, Intensive Care and Pain Management Department, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
Clinical Pharmacy Department, Faculty of Pharmacy (Girls), Al-Azhar University, Tanta, Cairo, 31511, Egypt.
J Med Case Rep. 2023 Feb 16;17(1):55. doi: 10.1186/s13256-023-03768-6.
Tranexamic acid is a well-known antifibrinolytic medication frequently prescribed to individuals with bleeding disorders. Following accidental intrathecal injection of tranexamic acid, major morbidities and fatalities have been documented. The aim of this case report is to present a novel method for management of intrathecal injection of tranexamic acid.
In this case report, a 400 mg intrathecal injection of tranexamic acid resulted in significant back and gluteal pain, myoclonus of the lower limbs, agitation, and widespread convulsions in a 31-year-old Egyptian male with history of left arm and right leg fracture. Immediate intravenous sedation with midazolam (5 mg) and fentanyl (50 μg) was delivered with no response in seizure termination. A 1000 mg phenytoin intravenous infusion and subsequently, induction of general anesthesia was performed by thiopental sodium (250 mg) and atracurium (50 mg) infusion, and the trachea of the patient was intubated. Maintenance of anesthesia was achieved by isoflurane 1.2 minimum alveolar concentration and atracurium 10 mg every 20 minutes, and subsequent doses of thiopental sodium (100 mg) to control seizures. The patient developed focal seizures in the hand and leg, so cerebrospinal fluid lavage was done by inserting two spinal 22-gauge Quincke tip needles, one on level L2-L3 (drainage) and the other on L4-L5. Intrathecal normal saline infusion (150 ml) was done over an hour by passive flow. After cerebrospinal fluid lavage and the patient's stabilization was obtained, he was transferred to the intensive care unit.
Early and continuous intrathecal lavage with normal saline, with the airway, breathing, and circulation protocol is highly recommended to decrease morbidity and mortality. The selection of the inhalational drug as a sedative and for brain protection in the intensive care unit provided possible benefits in management of this event with medication errors.
氨甲环酸是一种常用于治疗出血性疾病的知名抗纤维蛋白溶药物。已有研究报道鞘内注射氨甲环酸后会导致严重的并发症甚至死亡。本病例报告旨在提出一种治疗鞘内注射氨甲环酸的新方法。
一名 31 岁的埃及男性,有左手臂和右小腿骨折病史,在接受 400mg 氨甲环酸鞘内注射后出现严重背痛和臀部疼痛、下肢肌阵挛、躁动不安和广泛抽搐。立即静脉注射咪达唑仑(5mg)和芬太尼(50μg),但未能终止癫痫发作。随后给予 1000mg 苯妥英钠静脉滴注,继而静脉输注硫喷妥钠(250mg)和阿曲库铵(50mg)以诱导全身麻醉,并为患者进行气管插管。维持麻醉采用 1.2 最低肺泡有效浓度异氟醚和每 20 分钟 10mg 阿曲库铵,随后给予硫喷妥钠(100mg)以控制癫痫发作。患者出现手部和腿部局灶性癫痫发作,因此通过插入两个 22 号昆克(Quincke)尖端脊柱针进行脑脊液灌洗,一个位于 L2-L3 水平(引流),另一个位于 L4-L5 水平。通过被动流动在 1 小时内输注 150ml 等渗盐水。在完成脑脊液灌洗和患者稳定后,将其转至重症监护病房。
强烈推荐早期持续进行鞘内生理盐水灌洗,并遵循气道、呼吸和循环方案,以降低发病率和死亡率。在重症监护病房中选择吸入性药物作为镇静剂和脑保护剂可能有助于药物错误引起的此类事件的管理。